McDermott Advises Gleamer on its Acquisition of Pixyl and Caerus Medical - McDermott Will & Emery

McDermott Advises Gleamer on its Acquisition of Pixyl and Caerus Medical

Overview


McDermott Will & Emery advised Gleamer, a leading company in AI medical imaging, on its acquisition of Pixyl, a Grenoble-based medtech specialising in brain MRI, and Caerus Medical, which specialises in the detection of lumbar pathologies.

The McDermott team involved comprised:

  • Diana Hund, partner, Côme Wirz, Counsel, Marie Mouly and Agathe Bourdillon, associates, on corporate aspects
  • Côme de Saint-Vincent, partner, on tax law aspects
  • Charles de Raignac, Counsel, on intellectual property aspects

About McDermott


McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.